Rare diseases
Investigational molecules
Locations
Study on Long-term Safety of Seralutinib for Patients with Pulmonary Arterial Hypertension
ItalyStudy Comparing Savolitinib and Durvalumab with Sunitinib and Durvalumab for Patients with Advanced Papillary Renal Cell Carcinoma
ItalyLong-Term Safety Study of Valoctocogene Roxaparvovec for Patients with Severe Hemophilia A
ItalyStudy on Vedolizumab for Children with Moderate to Severe Ulcerative Colitis
ItalyStudy Comparing Lorlatinib and Crizotinib for Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer
ItalyStudy of Lenvatinib for Children and Young Adults with Relapsed or Refractory Solid Tumors, Including High Grade Glioma and Rhabdomyosarcoma
ItalyStudy on the Long-term Safety and Efficacy of Ralinepag for Patients with Pulmonary Arterial Hypertension
ItalyStudy Comparing Datopotamab Deruxtecan to Chemotherapy in Patients with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
ItalyStudy Comparing Ibrexafungerp and Fluconazole for Treating Candidemia or Invasive Candidiasis in Patients
ItalyStudy of Entrectinib in Children and Adolescents with Advanced or Metastatic Solid Tumors or Primary CNS Tumors with No Satisfactory Treatment Options
ItalyStudy Comparing Ipilimumab and Nivolumab with Standard Nivolumab for Patients with Stage III Melanoma
ItalyStudy Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
